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Cognitive aging and onset of dementia initially affect 
short-term memory, whereas long-term memory is 
largely retained. A consistent finding in the cognitive 
aging literature is the general slowing in mental 
processing speed, manifesting as increased reaction 
times during cognitive tasks [1]. Compared to young 
adults, middle age and older adults exhibit slowing in 
mental processing speed during working memory tasks 
[2]. Additionally, neural responses in  the  visual  cortex  
 
in response to visual stimuli are delayed in older 
individuals [3]. Multiple brain imaging studies have 
demonstrated that to accomplish a simple cognitive 
task, older adults require the activation of additional 
brain networks than young adults, possibly as a 
compensatory mechanism [4, 5, 6, 7].  
 
Despite progress in cognitive and brain aging research, 
the molecular and cellular basis for inter-individual 
differences in brain aging and why some older adults 
retain their sharp mind, is not yet well understood. 
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86)  from a well‐characterized  longitudinal cohort were  recruited and performed a modified delayed match‐to‐
sample task. The rs3764030 polymorphism was genotyped and participants were grouped based on the presence
of the A allele into GG and AA/AG. Carriers of the A allele maintained their speed of memory retrieval over age
compared  to GG  carriers  (p  =  0.026  slope  of  the  regression  line  between AA  and AG  versus GG  groups).    To
validate  the  results, 12 older adults  from  the same cohort participated  in a different version of  the short‐term
memory task.  Reaction times were significantly slower with age in older adults with G allele (p < 0.001).  These
findings support a role for rs3764030 in maintaining faster mental processing speed over aging. 
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Significant relations of genetic factors and individual 
differences in working memory performance of healthy, 
cognitively intact, older adults have been demonstrated 
[8]. These previous studies implicated the contribution of 
genetic variation in dopaminergic/noradrenergic genes in 
cortical activity, and to inter-individual variation in 
working memory and decision behavior.  Other neuro-
transmitter systems are also important in memory 
performance, but have been understudied.  Of particular 
interest is the N-methyl-D-aspartate (NMDA) receptor, 
an ionotropic glutamate receptor central in synaptic 
plasticity underlying learning and memory formation 
[9,10]. Dysregulation of the NMDA receptor is used to 
model dementias and Alzheimer’s disease (AD) [11,12] 
in rodents. A mouse model of AD demonstrated that 
soluble amyloid beta oligomers can interact with the pore 
forming GluN2B subunit to induce hyperexcitability of 
the NMDA receptor, blocking long term synaptic 
potential and inducing excitotoxicity [13].  
 
A genome wide association study (GWAS) identified 
two single nucleotide polymorphisms (SNPs) in introns 
of the GRIN2B gene (GRIN2B), encoding the GluN2B 
subunit, that were significantly over-represented in 
patients with AD [14]. This was the first finding of a 
genetic association between GRIN2B and an 
endophenotype. The GluN2B subunit is expressed in 
neurons in the hippocampus and forebrain. Genetic and 
pharmacological animal studies demonstrated that 
genetic ablation of GRIN2B or pharmacological 
inhibition of GluN2B resulted in decreased memory 
formation and consolidation [15, 16]. In contrast, 
transgenic animals overexpressing GluN2B displayed 
superior learning and memory performance compared to 
wild types [17]. In addition, decreased levels of 
GluN2B protein are correlated with advanced age in the 
hippocampus of aging mice [18] and decreased levels of 
GRIN2B mRNA during Alzheimer’s disease progression 
[19].  Interestingly, memory in aged mice can be rescued 
by enhanced expression of GluN2B [20], suggesting an 
approach for developing cognitive enhancers. 
 
Transcription of GRIN2B is controlled by several 
proteins including members of the E26 transforming-
specific (ETS) transcription factor family [21, 22, 23], 
cyclic AMP response element binding protein (CREB), 
and nuclear factor kappa B (NF-κB). The ETS 
transcription factor family is characterized by a central 
5’-GGA(A/T)-3’ DNA binding site with flanking 
sequences that are thought to contribute to the ETS 
binding specificity [24]. At present, 28 members of the 
ETS family, subdivided into 12 subgroups, have been 
identified in humans [24, 25].  Researchers have used 
combined chromatin immunoprecipitation, microarrays, 
or massively parallel sequence analysis to identify a 
subset of ETS transcription factors that preferentially 
bind the 5’-CCGGAACT-3’ eight nucleotide sequence 
in various cell types [24,26]. In particular Elk-1, known 
for its role in pro-apoptosis and pro-differentiation in 
neurons, has been shown to be involved in learning and 
memory [27, 28].   
 
Here, we investigated the role of the single nucleotide 
polymorphism (SNP) rs3764030 within the GRIN2B 
promoter region in working memory retrieval in 
healthy, cognitively intact older adults. We demonstrate 
in two experiments that the rs3764030 G>A SNP forms 
a de novo ETS binding site resulting in a gain-of-
function phenotype, which is associated with 




The SNP rs3764030 A allele creates a novel in vitro 
ETS transcription factor binding site 
 
We tested the hypothesis that a SNP (rs 3764030, G>A) 
within the promoter region of GRIN2B gene produces a 
de novo ETS family transcription factor binding site.  
An in vitro DNA binding assay was developed using 
purified Elk-1, an ETS family member expressed in the 
central nervous system [28], and DNA targets 
containing either (1) the consensus ETS core binding 
site (GGAA/T), (2) the ETS binding site identified in 
the GRIN2B promoter region (GGAA, A allele), or (3) 
without the ETS binding site (GGGA, G allele).  The 
results in Figure 1 show that the A allele DNA probe 
bound recombinant Elk-1 to a greater extent than the G 
allele DNA probe (Panel A).  When the same gel was 
stained for protein, it was readily apparent that the A 
allele DNA probe had more protein associated with it 
than the G allele DNA probe (Panel B).   
 
NMDA receptor activation in N2a cells transfected 
with rs3764030 A allele plasmid induced greater 
reporter gene activity than transfection with 
rs3764030 G allele 
 
Murine neuron-like N2a cells, which express Elk-1 [29] 
and NMDA receptors [30], were used to study the 
function of the SNP rs3764030.  Differentiated cells 
were transfected with plasmids containing either the 
rs3764030 A or G allele and firefly luciferase and a 
second plasmid containing Renilla luciferase.  
Transfected cells were stimulated with different 
concentrations of NMDA (0, 10, 30, 50, 70 µM) and 
luciferase activities measured.  A dose-dependent 
increase in Firefly/Renilla luciferase activity was seen for 
the A allele (Fig. 2). N2a cells transfected with the SNP 
rs3764030 G allele did not respond to NMDA.  These 
data suggest that the A allele produces an NMDA 
receptor gain-of-function phenotype. 


















































































































Figure 1.   Binding of  recombinant Elk‐1 protein  to dsDNAs containing  the  rs3764030 variant A
allele  from  the  human  GRIN2B  gene  promoter.    Double‐stranded  DNA  targets  (Methods)  were
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Participant characteristics 
 
A description of the 28 healthy aged adults in 
Experiment 1 stratified by rs3764030 genotype is 
provided in Table 1. 
 
Participants (n = 28, 15 GG vs 13 A allele carriers):  
allele frequencies met Hardy-Weinberg expectation 
based on frequencies observed in European populations. 
 
When stratified by A allele carriers and GG genotypes, 
the groups did not differ based on age, sex, education, 
or APOE ε4 carrier status (Table 1).  Both genotype 
groups had high cognitive function and had comparable 
mean scores of 29 on the Mini-Mental State Exam. 









































Experiment 1.  Association of rs3764030 genotype 
with memory performance 
 
The NMDA receptor has been shown to be critical for 
learning and memory. We therefore investigated if the 
SNP rs3764030 in the GRIN2B promoter region would 
correlate with a memory performance phenotype. We 
hypothesized that aged individuals with the SNP 
rs3764030 A allele would perform better in a visual 
memory test than those with a homogenous G allele. 
Using the Delayed Match-to-Sample (DMS) task, we 
determined that there was a significant correlation 
between participants’ age and reaction time when 
grouped based on SNP rs3764030 genotype.  A positive 
correlation between age and reaction time was found in 











































 A carrier GG P-value 
Age 75.4 ± 5.5 73.5 ± 6.0 0.39 
Sex (M/F) 6/7 6/9 0.96 
Education 
(Years) 
16.1 ± 2.8 16.2 ± 2.6 0.91 
MMSE 29.1 ± 0.86 29.2 ± 0.68 0.34 
APOE ε4 
Status (0/1) 






group differences.   A  significant  difference  in  the  slopes  of  the  regression  lines was
observed  for A allele carriers  (‐3.99 ± SE 3.47) versus the GG genotype group  (5.84 ± SE
2.28) (p = 0.026).  R2 for GG regression was 0.336 while R2 for A allele carriers was 0.107. 
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jects in the AA and AG genotype group (A allele 
carriers) had a negative correlation between age and 
reaction time (Fig. 3).  The slopes of the regression lines 
differed significantly between subjects with and without 
an A allele (-3.99 ± SE 3.47 for A allele carriers vs 5.84 
± SE 2.28 for GG; t(24) = 2.37,  p = 0.026).  The 
negative slope of the regression line for A allele carriers 
was associated with improved performance, but was not 
significantly different from a flat slope (p = 0.275).  
This may be due to the dispersion from combining AA 
and AG genotypes.  The R2 for GG regression was 
0.336 while R2 for A allele carriers was 0.107, 
indicating greater variability in reaction time.  In a 
different measure, mean reaction time was not 
significantly different between A allele carriers and the 
GG genotype group (A allele carriers: 583 ± 81 msec; 
GG 583 ± 54 msec; p = 0.490, Students’ t-test).   
 
Experiment 2.  Replication sample 
  
To validate the results from the Experiment 1, we 
performed a second experiment using a shorter and 
slightly simpler version of the working memory task 
(See Methods section).   
 
The results from Experiment 2 showed GG  and A allele 
carrier did not differ in memory accuracy (on average 





























fered in reaction times in repeated retrieval of visual 
target held in working memory.  GG indiviuals  had a 
positive correlation between age and reaction times of 
3rd retrieval of memory target (Fig. 4).  That is, 
individuals with the GG genotype had increased 
reaction times of memory retrieval with age.  In 
contrast, A allele carriers (AA and AG genotypes) did 
not show such trend.  The A allele carriers reactions 
times even decreased slightly with age (Fig. 5).  The 
slopes of the regression lines were significantly 
different (-3.58 ± SE 0.21 for A allele carriers versus 
GG genotype 13.1 ± SE 0.20, t(8) = 58.5,  p < 0.001).   





Summary of results 
  
We tested the hypothesis that individual differences in 
processing speed are partially determined by a SNP 
within the promoter of the GRIN2B gene.  In two 
experiments, memory performance among A allele 
carriers, predicted better performance during aging.  
These findings in two groups of cognitively normal 
aging adults suggest that the A allele may confer a 
protective effect on one aspect of memory performance.  
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was not associated with differences in mean reaction 
times. However, A allele carriers showed decreased 
reaction time with age compared with the GG genotype 
(p = 0.026 based on difference in slope of the regression 
line between GG and A allele carriers).   
 
Changes in expression of the GRIN2B gene and activity 
of GluN2B subunit containing NMDA receptors are 
known to affect memory and cognition [17].   From the 
genetic perspective, variation in the human GRIN2B 
gene is known to be associated with normal and 
impaired memory [14,31], although the molecular and 
cellular mechanisms underlying these changes in 
memory performance are not well understood.  In this 
study we determined a biological effect of the GRIN2B 
promoter SNP, rs3764030 G>A, showing that the A 
allele in transfected N2a cells, responded to NMDA 
agonism in a dose-dependent manner relative to the 
common G allele.  In addition, we showed that the A 
allele was capable of binding the ETS transcription 
factor, Elk-1, in vitro.  These observations were the 
mechanistic basis for supporting a gain-of-function gene 
variant and for combining genotype groups (A allele 
carriers vs non-carriers) for genetic association studies.   
Evidence from neuroimaging studies indicates that 
working memory involves multiple cortical networks, 
e.g. the prefrontal, temporal cortex, and parietal, 
parahippocampus,  and   early  visual  occipital  cortices  




























known that as the brain ages, the level of GRIN2B 
mRNA and GluN2B protein is reduced in certain brain 
regions [18,35,36,37,38]. While other SNPs, by 
individual or by haplotype-based analyses have 
supported the idea that GRIN2B has a role in gene 
expression and memory performance [39] and in AD 
[40], we think the current study is the first report of a 
SNP that affects GRIN2B mRNA levels by an activity-
dependent mechanism.  Knowing a functional 
polymorphism that increases levels of GRIN2B mRNA 
and possibly the number of GluN2B subunits suggests a 
way for protecting the brain from age-related cognitive 
decline.  However, it should be noted that our study has 
limitations that will need to be addressed in future 
studies.  First, the sample size was small, so these 
findings must be considered preliminary.  We describe 
the association of one genetic variant on memory 
performance.  SNP rs3764030 may interact with other 
variants of the GRIN2B gene or may be in linkage 
disequilibrium with other functional variants. An 
examination of linkage disequilibrium relationships 
among SNPs approximately 10 kb 5’ and 10 kb 3’ from 
SNP rs3764030 (European-American population of 
Northern and Western European ancestry, CEU, 1000 
Genomes database) indicated that while linkage 
disequilibrium (LD) approached 1.0 based on D’, the 
average R2 was low between rs3764030 and flanking 
SNPs (highest R2 value was 0.237)(Figure S1, Panel B, 
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R2  within 20kb of rs3764030).  Therefore, at least for 
individuals of Northern and Western European descent, 
the selected SNPs in this 20 kb region have a similar 
frequency as rs3764030 but have no better predictability 
than the functional variant we selected for analysis in 
the current study.  Addressing the role of other genetic 
variants that regulate expression of the GRIN2B gene 
will require additional DNA sequence screening, 
mRNA expression analysis, and association analysis 
using larger cohorts. 
 
Other questions relating to the role of ETS domain 
proteins in the brain are worthy of future exploration.  
The ETS domain transcription factor family has 27 
known members that are expressed by different human 
cells.  Our initial focus on Elk-1 was because it is 
expressed in the brain, among other tissues.  Although 
these ETS transcription factors display binding site 
selectivity based on differences in nucleotide sequences 
that flank the core GGAA/T motif in vitro, convergent 
findings from different groups have shown that ETS 
family member proteins display overlapping DNA 
binding patterns between some family members in vivo 
[41,42].  In future studies, it will be of great interest to 
identify the ETS domain transcription factor that binds 
the A allele in vivo.  This information may have 
implications in defining cellular changes that occur in 
the aging human brain that may then be used to predict 




Our results from two experiments support the idea that 
presence of the A allele of SNP rs3764030 positively 
influenced an individual’s mental processing speed 
during working memory indexing. Alternatively, 
individuals with the G allele, while having slower 
responses with increasing age, may have a stronger 
capability to suppress distractors.  Either interpretation 
is consistent with the idea that changes in subunit 
stoichiometry of NMDA receptors confer distinct 
functional properties on memory.  The grouping of A 
allele-genotypes for association analyses was justified 
based on reporter gene assays and gain-of-function ETS 
transcription factor binding to DNA.  Future 
longitudinal follow-up in larger populations will bring 
insights of whether GRIN2B gene variation might be a 
potential indicator for cognitive reserve or may serve as 






Participants were drawn from a large aging cohort of 
over 400 older adults followed by the University of 
Kentucky (UK)-Alzheimer’s Disease Center (ADC).  
All participants were enrolled from a prior existing 
longitudinal study on aging and brain health that 
collects demographic, health and neuropsychological 
data, and blood samples annually [43]. All research 
activities were approved by the University of Kentucky 
Institutional Review Board and all participants provided 
informed written consent prior to any research 
activities.    
  
Individuals were not invited to participate in the study if 
they had a history of substance abuse, traumatic brain 
injury, major psychiatric illness, or illness affecting the 
central nervous system such as for example encephalitis 
or meningitis. Battery of Neuropsychological tests 
including the Mini-Mental State Examination were 
available for all participants in the present study. 
Subjects agreed to provide blood for genetic testing and 
to participate in annual clinical assessment and 
neuropsychological testing.  In the first group 
(described later as Experiment 1), 28 (17 females) 
healthy, cognitively normal, right-handed, English-
speaking, adults aged 65-86 participated in the current 
study.  
  
To cross-validate the results of Experiment 1, 16 
healthy older adults from the general cohort described 
above participated in the second experiment. Twelve of 
the 16 older adults had rs3764030 genotypes available 




Genomic DNA was isolated from whole blood as 
described previously [44].  For Experiment 2, genotypes 
for SNP rs3764030 were obtained from the UK-ADC 
samples. The older adults’ blood samples were 
contributed to the Alzheimer’s Disease Genetics 
Consortium, and genotype calls were returned to the 
UK-ADC.  The genotyping data were extracted from 
the raw genotype file first and then merged with the 
behavioral performance data.  The minor allele (A) was 
determined by calculating minor allele frequency based 
on the raw UK genotype files. SNP rs3764030 is 
detected in human populations of European and Asian 
origin.  Details for genotyping reactions are given 
below.   
   
Primers 
 
DNA, extracted from blood samples, were genotyped 
for the rs3764030 G>A SNP in the human GRIN2B 
promoter region using a 5’ exonuclease assay with 
allele-specific fluorescence detection probes. The 
rs3764030 SNP is located at nucleotide position 
13,980,398 (Reference Sequence NC_000012.2) on 
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Chromosome 12. The allele-specific detection probes 
were fluorescently labeled with either FAM or VIC at 
the 5’-end and linked to a non-fluorescent quencher 
(MGB) at the 3’-end.  
Amplification primers 
Forward: 5’-caaagcgtccccttcctaag-3’ 
Reverse: 5’- ctctcgtgtgcactctgtgg-3’.  
The sequence of the allele-specific detection probes 
were:  
G allele (shown as opposite strand, C): 5’-
ttgattcgcgtgtccccc-3’ 
A allele (shown as opposite strand, T): 5’- 
ttgattcgcgtgttcccc-3’. 
APOE variants rs429358 (C>T, Arg112Cys) and rs7412 
(C>T, Arg158Cys) were genotyped as described 
previously [45]. 
 
General method for performing 5’-exonuclease assay 
 
Genotyping reactions (5 µl) were performed in 96-well 
plates containing 10 ng of genomic DNA, 0.5 µM of 
primers, 0.2 µM of probes, and 2.5 µl of Master Mix 
(Thermo). The reaction thermal cycle program 
consisted of 50ºC for 2 min, 95ºC for 10 min, followed 
by 40 cycles of 95ºC for 15 s, 59 or 60ºC for 1 min. End 
point amplification genotypes were determined using 
BioRad Sequence Detector. Genotyping accuracy was 
verified by re-genotyping at least 10% of randomly 
selected DNA samples using the same assay or direct 
sequence analysis. Genotyping accuracy was >99% and 
genotyping completion was 99%. 
 
Genotypes were independently confirmed using direct 
sequence analysis with no discrepancies. Genotype 
frequencies met Hardy-Weinberg expectations in the 
study population.   
 
Molecular and cellular characterization of a 
functional GRIN2B SNP 
 
Luciferase vector construction 
To characterize potential effects of this SNP on 
transcription, we used PCR to amplify a 1.7 kb genomic 
region spanning from 1530 bps upstream of the human 
GRIN2B gene transcription start site into GRIN2B gene 
untranslated exon 4.   Exon organization was based on 
RefSeqGene NG_031854.1 (Fig. S1, Panel A 
Supplementary Material).  For PCR, the Forward 
primer: 5' GAGCTCAAACCACTTCCTCCGGCTTC 3' 
and the Reverse primer: 5' CTCGAGGCCAACCTCTA 
GACGGACA 3'.  Individuals with genotype GG and 
AA are selected to PCR amplify the 1.7kb region for 
cloning. The PCR product was inserted into the pGL 
4.10 plasmid (Promega, Madison, WI, USA) that is a 
promoter-less vector containing a luciferase reporter 
gene.  Four plasmid constructs were designed, one for 
each combination of alleles (A or G allele, positive and 
negative orientation), and the DNA strand transcribed: 
(1) positive orientation with allele A on the upper 
transcribed strand (A+ plasmid), (2) positive orientation 
with allele G (G+ plasmid), (3) negative orientation 
with allele A on the lower untranscribed strand (A- 
plasmid), and (4) negative orientation with allele G (G- 
plasmid). Orientations and alleles in the constructs were 
confirmed by direct sequencing with an  ABI 310 
genetic sequencer (Applied Biosystems, Foster City, 
CA, USA). 
 
Functional NMDA receptor analysis  
Murine N2a neuroblastoma cells (ATCC, Manassas, 
VA, USA) were grown in RPMI 1640 cell culture 
medium (Thermo Fisher, Pittsburgh, PA, USA) 
supplemented with 5% fetal bovine serum (FBS) in 5% 
CO2 at 37°C until cells were approximately 80% 
confluent. Cells were transferred into laminin- and poly-
L-lysine coated 96 well cell culture plates (Corning 
3904, Thermo Fisher Scientific, Pittsburgh, PA, USA) 
and grown in serum-free RPMI 1640 medium 24-48 hrs 
prior to transfection. Cell differentiation was induced by 
adding 1 µM retinoic acid (Sigma-Aldrich, St. Louis, 
MO, USA) to the culture medium for 24 hrs. 
Differentiated cells were co-transfected with one of the 
four pGL4.10 plasmid constructs encoding the Firefly 
luciferase reporter gene and the control pGL4.75 
plasmid encoding the Renilla luciferase reporter gene 
using the Lipofectamine transfection reagent (Thermo 
Fisher) according to manufacturer’s instructions. 
Transfected cells were activated by adding 0, 30, 50, 70, 
or 90 µ M NDA (Sigma-Aldrich) to the culture medium 
for 4-6 hrs to induce transcription factors. Solutions 
were replaced with RPMI 1640 medium containing 
10% Fetal Bovine Serum (Atlanta Biologicals, Flowery 
Branch, GA, USA) for 40-44 hrs at 37º C in 5% CO2. 
Luciferase activities were measured using a Synergy 4 
plate reader (Biotek, Winooski, VT, USA). Each 
NMDA concentration was tested three times for 
statistical analysis.  
 
Electrophoretic mobility shift assay  
  
The electrophoretic mobility shift assay (EMSA) was 
used to monitor interactions between the ETS domain 
transcription factor Elk-1 and its DNA recognition 
sequence in vitro. The following sequences were used 
for producing a positive control double stranded DNA 
(dsDNA) targets based on Wei et al.,( 2010):  
Positive control 
Forward: 5' ACGCTAACCGGATATAACGCTA 3'  
Reverse: 5' TAGCGTTATATCCGGTTAGCGT 3' 
GRIN2B sequences were:  
GRIN2B A allele  
Forward: 5' CATCTCCGGGGAACACGCGAA 3'  
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Reverse: 5' TTCGCGTGTTCCCCGGAGATG 3' 
GRIN2B G allele  
Forward: 5' CATCTCCGGGGGACACGCGAA 3'  
Reverse: 5' TTCGCGTGTCCCCCGGAGATG 3' 
 
Complementary oligonucleotides were annealed with 
the Bio-Rad C1000 thermocycler (Bio-Rad, Berkeley, 
CA, USA) in annealing buffer (10 mM Tris-HCl (pH 
8.0), 1 mM EDTA, and 50 mM NaCl ) with 1°C / 1 min 
decreasing from 95°C to 20°C.  The annealed dsDNA 
was incubated on ice for 1 h with 1 μg recombinant 
human Elk-1 protein (Sigma-Aldrich, St. Louis, MO, 
USA) in EMSA buffer (50 mM HEPES pH7.5, 10 mM 
MgCl2, 5% glycerol, 1 mM DTT, 0.3% BSA, 1 mM 
EDTA). The EMSA was run in a 6% retardation gel 
(Thermo Fisher Scientific) using 95V for 80 min. The 
gel was stained with EMSA SYBR Green and SYPRO 
Ruby kit (Catalog  E-33075; Thermo Fisher Scientific) 
according to manufacturer’s instructions. The gel was 




































Experimental paradigm to study visual working 
memory  
 
Visual stimuli    
Stimuli consisted of 216 two dimensional pictures of 
common objects taken from [46]. Each object was 
presented in white-black within a rectangular area of 
approximately, 8.3 by 5.8 cm. At the beginning of each 
memory trial, sample pictures were also presented with 
a 6.5 mm green border. Each picture group was normed 
for familiarity and complexity.  All 216 stimuli pictures 
were transformed using Fourier analysis. They were 
named scramble pictures. For Experiment 1, scramble 
pictures were seen between trials, that was not the case 
for Experiment 2. 
 
The modified delayed match-to-sample task 
Experiment 1.  The short-term memory task consisted 
of study and test phase.  During the study phase, 
participants memorized 80 line drawing pictures until 







































trial.  Subjects were  instructed  to  forget  the previous  sample  target object only when a new  sample  target object
appeared. For Experiment 1, a  study phase was  included. During  the  study phase, participants memorized 80  line
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Thus, half of the images were studied during the test 
phase.  The test phase included 80 trials separated into 8 
blocks of 10 trials each.  Each trial began with the 
presentation of a sample target object for 2000 msec 
and was distinguished by a green border (Fig. 6).  The 
sample target object was followed (ISI = 700 ± 100 
msec) by 10 successive test objects with a stimulus 
duration of 2000 msec (ISI = 500 ± 200 msec).  Each 
trial lasted 27.5 seconds.  The test portion of each trial 
contained a pseudo-random presentation of target match 
and nonmatch objects where the match, a studied 
nonmatch, and a new nonmatch were presented three 
times each, resulting in nine of the ten test items in a 
trial.   One additional ‘filler’ object was included in 
each trial to reduce the potential for subject expectancy 
and served either as a 4th target (16.7 % of trials), 4th 
studied nonmatch (16.7 % of trials), 4th new nonmatch 
(16.7 % of trials), or a new nonmatch never previously 
shown (50 % of trials). None of the objects, whether 
serving as a target or nonmatch, were used in any 
subsequent trials.  Across trials, stimuli from the three 
experimental conditions were equally distributed across 
all 10 serial positions. Figure 6 illustrates a memory trial. 
  
Participants were told to hold the sample target object in 
mind and indicate whether the following 10 test objects 
were the same or different from the sample target. 
Assignment of hands to indicate a target match versus a 
nonmatch object was counterbalanced across right- 
handed subjects.  Subjects were also instructed to forget 
the previous sample target object only when a new 
sample target object appeared in the next trial (Fig. 6). 
Reaction time and accuracy of behavioral responses 
were recorded. 
  
Experiment 2. The version used in the Experiment 2 
was shorter, and without study phase. Total 60 trials 
were performed in two blocks of 30 trials each, with a 
short break between blocks. The working memory task 
lasted approximately 18 minutes overall.  For each 
memory trial, a sample image with a green border was 
initially presented for 3 sec the participant indicated 
whether each of five successive test images matched or 
did not match the sample. A fixation with jittered delay 
(1.1–1.4 seconds) was placed between each test image. 
No scramble images were seen between trials as it was 
in Experiment 1 (Also see illustration and description of 
the task in Experiment 2 in a previous publication [47]).  
 
Behavioral data analysis 
  
Accuracy of behavioral responses (number of correct 
responses), learning rate, and reaction times in 
milliseconds (msec) were determined for each object 
retrieval, new or studied item matching target, new or 
studied non-match distractors as previously described 
[2]. Exploratory analysis included the use of the 
descriptive statistics including means, standard 
deviations for continuous variables.  Results were 
presented over the three repeated retrieval of memory 
target matches. Two sample t-tests were used to 
compare means and regression models were used to 
compare slopes   All data analyses were performed in R 
(version 3.3.3). 
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transcription  start  site  in  brain  is  shown  by  a  large  left‐pointing  arrow.   Other  transcription  start  sites  are  shown with
smaller left‐pointing arrows.  The non‐coding exons are known to undergo extensive alternative pre‐mRNA splicing (shown
as open boxes).   Nucleotide positions  from  the  reference sequence are shown above  the horizontal  line.   Adapted  from
NCBI:   www.ncbi.nlm.nih.gov RefSeqGene NG_031854.1.   GRIN2B markers  used  in  linkage  equilibrium  (LD)  analysis  are
indicated by  their dbSNP  rs  identifier.   Orientation of  the map  is shown with  transcription proceeding  from  right  to  left.
Panel (B)  Pairwise LD relationships for 27 markers in the CEU population with values shown in color below the GRIN2B gene
map:     R2  (left) and D’  (right).   Bright red  indicates a region of high LD  (R2 > 0.8, D’ > 0.8) with yellow  indicating areas of
lower LD.  The Lowest LD (R2 < 0.1, D’ < 0.1) are shown in white.   Over the entire 20 kb region, R2 was low while D’ was high. 
